- Home
- TLX vs BIPC Comparison
TLX vs BIPC Comparison
Compare TLX & BIPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLX
- BIPC
- Stock Information
- Founded
- TLX 2015
- BIPC 2019
- Country
- TLX Australia
- BIPC United States
- Employees
- TLX N/A
- BIPC N/A
- Industry
- TLX Biotechnology: Pharmaceutical Preparations
- BIPC Marine Transportation
- Sector
- TLX Health Care
- BIPC Consumer Discretionary
- Exchange
- TLX Nasdaq
- BIPC Nasdaq
- Market Cap
- TLX 4.0B
- BIPC 4.7B
- IPO Year
- TLX N/A
- BIPC N/A
- Fundamental
- Price
- TLX $9.51
- BIPC $40.22
- Analyst Decision
- TLX Strong Buy
- BIPC Hold
- Analyst Count
- TLX 3
- BIPC 1
- Target Price
- TLX $22.33
- BIPC $46.00
- AVG Volume (30 Days)
- TLX 217.0K
- BIPC 576.7K
- Earning Date
- TLX 01-01-0001
- BIPC 01-01-0001
- Dividend Yield
- TLX N/A
- BIPC 4.28%
- EPS Growth
- TLX N/A
- BIPC N/A
- EPS
- TLX 0.04
- BIPC N/A
- Revenue
- TLX $664,225,558.00
- BIPC $3,651,000,000.00
- Revenue This Year
- TLX N/A
- BIPC $8.02
- Revenue Next Year
- TLX N/A
- BIPC $5.98
- P/E Ratio
- TLX $298.01
- BIPC N/A
- Revenue Growth
- TLX 55.35
- BIPC 11.38
- 52 Week Low
- TLX $9.48
- BIPC $32.08
- 52 Week High
- TLX $30.36
- BIPC $43.41
- Technical
- Relative Strength Index (RSI)
- TLX 31.15
- BIPC 51.51
- Support Level
- TLX $12.12
- BIPC $39.59
- Resistance Level
- TLX $12.58
- BIPC $40.83
- Average True Range (ATR)
- TLX 0.45
- BIPC 0.77
- MACD
- TLX 0.01
- BIPC 0.20
- Stochastic Oscillator
- TLX 0.98
- BIPC 74.07
About TLX Telix Pharmaceuticals Limited American Depositary Shares
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
About BIPC Brookfield Infrastructure Corporation
Brookfield Infrastructure Corp is an indirect subsidiary of the partnership of the diversified infrastructure owner and operators. Its business is comprised of a U.K. regulated distribution operation, a Brazilian regulated natural gas transmission operation and an international intermodal logistics operation. Geographically, the company generates a majority of its revenue from Brazil and rest from United Kingdom and the United States.